US Stock MarketDetailed Quotes

VTVT vTv Therapeutics

Watchlist
  • 16.4000
  • -0.9200-5.31%
Close Apr 1 16:00 ET
  • 16.4000
  • 0.00000.00%
Post 16:00 ET
42.84MMarket Cap-5.13P/E (TTM)

vTv Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
1.02M
17K
0
0
1M
0
0
0
0
0
Operating revenue
--1.02M
--17K
--0
--0
--1M
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-1.20%25.2M
4.29%4.91M
21.20%6.51M
-10.56%7.16M
-10.77%6.63M
3.84%25.5M
-25.90%4.71M
-5.64%5.37M
98.22%8M
-12.43%7.43M
Selling and administrative expenses
14.65%13.65M
4.13%2.68M
29.01%3.28M
12.30%3.72M
14.15%3.98M
-2.41%11.91M
7.58%2.57M
-3.42%2.54M
80.72%3.31M
-34.84%3.49M
-General and administrative expense
14.65%13.65M
4.13%2.68M
29.01%3.28M
12.30%3.72M
14.15%3.98M
-2.41%11.91M
7.58%2.57M
-3.42%2.54M
80.72%3.31M
-34.84%3.49M
Research and development costs
-15.07%11.55M
4.49%2.23M
14.16%3.22M
-26.69%3.44M
-32.80%2.65M
10.02%13.6M
-46.06%2.14M
-7.56%2.82M
112.74%4.69M
25.82%3.94M
Operating profit
5.18%-24.18M
-3.93%-4.89M
-21.20%-6.51M
10.56%-7.16M
24.24%-5.63M
-13.14%-25.5M
25.79%-4.71M
5.64%-5.37M
-98.66%-8M
-14.60%-7.43M
Net non-operating interest income expense
240.96%1.57M
429.63%429K
296.85%504K
266.23%553K
-21.00%79K
36.20%459K
-44.52%81K
-10.56%127K
202.00%151K
10,100.00%100K
Non-operating interest income
231.57%1.57M
387.50%429K
284.73%504K
261.44%553K
-21.00%79K
34.09%472K
-42.11%88K
-12.67%131K
206.00%153K
--100K
Non-operating interest expense
--0
--0
--0
--0
----
-13.33%13K
16.67%7K
-50.00%4K
--2K
----
Other net income (expense)
101.08%10K
-85.95%26K
104.91%162K
-69.75%193K
-123.89%-371K
65.43%-923K
72.90%185K
-4,275.95%-3.3M
659.65%638K
156.64%1.55M
Gain on sale of security
----
----
----
----
----
----
----
----
----
--1.6M
Other non- operating income (expenses)
101.08%10K
-85.95%26K
104.91%162K
-69.75%193K
-689.36%-371K
65.43%-923K
72.90%185K
-4,275.95%-3.3M
659.65%638K
98.29%-47K
Income before tax
12.94%-22.61M
0.09%-4.44M
31.62%-5.84M
11.12%-6.41M
-2.51%-5.92M
-4.39%-25.97M
27.08%-4.44M
-56.18%-8.54M
-76.26%-7.21M
37.40%-5.77M
Income tax
100K
0
0
0
100K
0
0
0
0
0
Net income
12.56%-22.71M
0.09%-4.44M
31.62%-5.84M
11.12%-6.41M
-4.24%-6.02M
-3.56%-25.97M
27.08%-4.44M
-56.18%-8.54M
-76.26%-7.21M
38.73%-5.77M
Net income continuous Operations
12.56%-22.71M
0.09%-4.44M
31.62%-5.84M
11.12%-6.41M
-4.24%-6.02M
-3.56%-25.97M
27.08%-4.44M
-56.18%-8.54M
-76.26%-7.21M
38.73%-5.77M
Minority interest income
25.77%-4.24M
16.61%-803K
43.96%-1.06M
22.80%-1.23M
9.49%-1.15M
3.27%-5.72M
28.40%-963K
-56.26%-1.89M
-69.36%-1.59M
47.25%-1.28M
Net income attributable to the parent company
8.83%-18.46M
-4.49%-3.63M
28.12%-4.78M
7.81%-5.18M
-8.14%-4.87M
-5.67%-20.25M
26.70%-3.48M
-56.16%-6.65M
-78.32%-5.62M
35.79%-4.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
8.83%-18.46M
-4.49%-3.63M
28.12%-4.78M
7.81%-5.18M
-8.14%-4.87M
-5.67%-20.25M
26.70%-3.48M
-56.16%-6.65M
-78.32%-5.62M
35.79%-4.5M
Basic earnings per share
67.04%-3.2
67.07%-0.55
72.41%-0.88
69.89%-0.81
45.83%-1.17
2.71%-9.71
30.42%-1.67
-59.50%-3.19
-68.13%-2.69
46.00%-2.16
Diluted earnings per share
67.04%-3.2
67.07%-0.55
72.41%-0.88
69.89%-0.81
45.83%-1.17
2.71%-9.71
30.42%-1.67
-59.50%-3.19
-68.13%-2.69
46.00%-2.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 1.02M17K001M00000
Operating revenue --1.02M--17K--0--0--1M--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -1.20%25.2M4.29%4.91M21.20%6.51M-10.56%7.16M-10.77%6.63M3.84%25.5M-25.90%4.71M-5.64%5.37M98.22%8M-12.43%7.43M
Selling and administrative expenses 14.65%13.65M4.13%2.68M29.01%3.28M12.30%3.72M14.15%3.98M-2.41%11.91M7.58%2.57M-3.42%2.54M80.72%3.31M-34.84%3.49M
-General and administrative expense 14.65%13.65M4.13%2.68M29.01%3.28M12.30%3.72M14.15%3.98M-2.41%11.91M7.58%2.57M-3.42%2.54M80.72%3.31M-34.84%3.49M
Research and development costs -15.07%11.55M4.49%2.23M14.16%3.22M-26.69%3.44M-32.80%2.65M10.02%13.6M-46.06%2.14M-7.56%2.82M112.74%4.69M25.82%3.94M
Operating profit 5.18%-24.18M-3.93%-4.89M-21.20%-6.51M10.56%-7.16M24.24%-5.63M-13.14%-25.5M25.79%-4.71M5.64%-5.37M-98.66%-8M-14.60%-7.43M
Net non-operating interest income expense 240.96%1.57M429.63%429K296.85%504K266.23%553K-21.00%79K36.20%459K-44.52%81K-10.56%127K202.00%151K10,100.00%100K
Non-operating interest income 231.57%1.57M387.50%429K284.73%504K261.44%553K-21.00%79K34.09%472K-42.11%88K-12.67%131K206.00%153K--100K
Non-operating interest expense --0--0--0--0-----13.33%13K16.67%7K-50.00%4K--2K----
Other net income (expense) 101.08%10K-85.95%26K104.91%162K-69.75%193K-123.89%-371K65.43%-923K72.90%185K-4,275.95%-3.3M659.65%638K156.64%1.55M
Gain on sale of security --------------------------------------1.6M
Other non- operating income (expenses) 101.08%10K-85.95%26K104.91%162K-69.75%193K-689.36%-371K65.43%-923K72.90%185K-4,275.95%-3.3M659.65%638K98.29%-47K
Income before tax 12.94%-22.61M0.09%-4.44M31.62%-5.84M11.12%-6.41M-2.51%-5.92M-4.39%-25.97M27.08%-4.44M-56.18%-8.54M-76.26%-7.21M37.40%-5.77M
Income tax 100K000100K00000
Net income 12.56%-22.71M0.09%-4.44M31.62%-5.84M11.12%-6.41M-4.24%-6.02M-3.56%-25.97M27.08%-4.44M-56.18%-8.54M-76.26%-7.21M38.73%-5.77M
Net income continuous Operations 12.56%-22.71M0.09%-4.44M31.62%-5.84M11.12%-6.41M-4.24%-6.02M-3.56%-25.97M27.08%-4.44M-56.18%-8.54M-76.26%-7.21M38.73%-5.77M
Minority interest income 25.77%-4.24M16.61%-803K43.96%-1.06M22.80%-1.23M9.49%-1.15M3.27%-5.72M28.40%-963K-56.26%-1.89M-69.36%-1.59M47.25%-1.28M
Net income attributable to the parent company 8.83%-18.46M-4.49%-3.63M28.12%-4.78M7.81%-5.18M-8.14%-4.87M-5.67%-20.25M26.70%-3.48M-56.16%-6.65M-78.32%-5.62M35.79%-4.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 8.83%-18.46M-4.49%-3.63M28.12%-4.78M7.81%-5.18M-8.14%-4.87M-5.67%-20.25M26.70%-3.48M-56.16%-6.65M-78.32%-5.62M35.79%-4.5M
Basic earnings per share 67.04%-3.267.07%-0.5572.41%-0.8869.89%-0.8145.83%-1.172.71%-9.7130.42%-1.67-59.50%-3.19-68.13%-2.6946.00%-2.16
Diluted earnings per share 67.04%-3.267.07%-0.5572.41%-0.8869.89%-0.8145.83%-1.172.71%-9.7130.42%-1.67-59.50%-3.19-68.13%-2.6946.00%-2.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Hutchmed (China)
HCM
16.060
Enerpac Tool
EPAC
46.150
Precision Drilling
PDS
47.780
4
YETI Holdings
YETI
33.690
5
Teradata Corp
TDC
22.750
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.